Cargando…
Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections Using Fascia Closure After EVAR—A Randomized Trial
BACKGROUND: Surgical site infections (SSI) in the groin after vascular surgery are common. The aim of the study was to evaluate the effect of negative pressure wound therapy (NPWT) on SSI incidence when applied on closed inguinal incisions after endovascular aneurysm repair (EVAR). METHODS: A multic...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636293/ https://www.ncbi.nlm.nih.gov/pubmed/36241857 http://dx.doi.org/10.1007/s00268-022-06740-5 |
_version_ | 1784824913327030272 |
---|---|
author | Svensson-Björk, Robert Hasselmann, Julien Asciutto, Giuseppe Zarrouk, Moncef Björk, Jonas Bilos, Linda Pirouzram, Artai Acosta, Stefan |
author_facet | Svensson-Björk, Robert Hasselmann, Julien Asciutto, Giuseppe Zarrouk, Moncef Björk, Jonas Bilos, Linda Pirouzram, Artai Acosta, Stefan |
author_sort | Svensson-Björk, Robert |
collection | PubMed |
description | BACKGROUND: Surgical site infections (SSI) in the groin after vascular surgery are common. The aim of the study was to evaluate the effect of negative pressure wound therapy (NPWT) on SSI incidence when applied on closed inguinal incisions after endovascular aneurysm repair (EVAR). METHODS: A multicenter randomized controlled trial (RCT). Between November 2013 and December 2020, 377 incisions (336 bilateral and 41 unilateral) from elective EVAR procedures with the primary intent of fascia closure were randomized and included, receiving either NPWT or a standard dressing. In bilateral incisions, each incision randomly received the opposite dressing of the other side, thereby becoming each other’s control. The primary endpoint was SSI incidence at 90 days postoperatively, analyzed on an intention-to-treat basis. Uni and bilaterally operated incisions were analyzed separately, and their respective p-values combined using Fisher’s method for combining P-values. Study protocol (NCT01913132). RESULTS: The SSI incidence at 90 days postoperatively in bilateral incisions was 1.8% (n = 3/168) in the NPWT and 4.8% (n = 8/168) in the standard dressing group, and in unilateral incisions 13.3% (n = 2/15) and 11.5% (n = 3/26), respectively (combined p = 0.49). In all SSIs, bacteria were isolated from incisional wound cultures. No additional SSIs were diagnosed between 90 days and 1 year follow-up. CONCLUSIONS: No evidence of difference in SSI incidence was seen in these low-risk inguinal incisions when comparing NPWT with standard dressings after EVAR with the primary intent of fascia closure. Clinical Trials: NCT01913132. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00268-022-06740-5. |
format | Online Article Text |
id | pubmed-9636293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-96362932022-11-06 Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections Using Fascia Closure After EVAR—A Randomized Trial Svensson-Björk, Robert Hasselmann, Julien Asciutto, Giuseppe Zarrouk, Moncef Björk, Jonas Bilos, Linda Pirouzram, Artai Acosta, Stefan World J Surg Original Scientific Report BACKGROUND: Surgical site infections (SSI) in the groin after vascular surgery are common. The aim of the study was to evaluate the effect of negative pressure wound therapy (NPWT) on SSI incidence when applied on closed inguinal incisions after endovascular aneurysm repair (EVAR). METHODS: A multicenter randomized controlled trial (RCT). Between November 2013 and December 2020, 377 incisions (336 bilateral and 41 unilateral) from elective EVAR procedures with the primary intent of fascia closure were randomized and included, receiving either NPWT or a standard dressing. In bilateral incisions, each incision randomly received the opposite dressing of the other side, thereby becoming each other’s control. The primary endpoint was SSI incidence at 90 days postoperatively, analyzed on an intention-to-treat basis. Uni and bilaterally operated incisions were analyzed separately, and their respective p-values combined using Fisher’s method for combining P-values. Study protocol (NCT01913132). RESULTS: The SSI incidence at 90 days postoperatively in bilateral incisions was 1.8% (n = 3/168) in the NPWT and 4.8% (n = 8/168) in the standard dressing group, and in unilateral incisions 13.3% (n = 2/15) and 11.5% (n = 3/26), respectively (combined p = 0.49). In all SSIs, bacteria were isolated from incisional wound cultures. No additional SSIs were diagnosed between 90 days and 1 year follow-up. CONCLUSIONS: No evidence of difference in SSI incidence was seen in these low-risk inguinal incisions when comparing NPWT with standard dressings after EVAR with the primary intent of fascia closure. Clinical Trials: NCT01913132. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00268-022-06740-5. Springer International Publishing 2022-10-14 2022 /pmc/articles/PMC9636293/ /pubmed/36241857 http://dx.doi.org/10.1007/s00268-022-06740-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Scientific Report Svensson-Björk, Robert Hasselmann, Julien Asciutto, Giuseppe Zarrouk, Moncef Björk, Jonas Bilos, Linda Pirouzram, Artai Acosta, Stefan Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections Using Fascia Closure After EVAR—A Randomized Trial |
title | Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections Using Fascia Closure After EVAR—A Randomized Trial |
title_full | Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections Using Fascia Closure After EVAR—A Randomized Trial |
title_fullStr | Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections Using Fascia Closure After EVAR—A Randomized Trial |
title_full_unstemmed | Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections Using Fascia Closure After EVAR—A Randomized Trial |
title_short | Negative Pressure Wound Therapy for the Prevention of Surgical Site Infections Using Fascia Closure After EVAR—A Randomized Trial |
title_sort | negative pressure wound therapy for the prevention of surgical site infections using fascia closure after evar—a randomized trial |
topic | Original Scientific Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636293/ https://www.ncbi.nlm.nih.gov/pubmed/36241857 http://dx.doi.org/10.1007/s00268-022-06740-5 |
work_keys_str_mv | AT svenssonbjorkrobert negativepressurewoundtherapyforthepreventionofsurgicalsiteinfectionsusingfasciaclosureafterevararandomizedtrial AT hasselmannjulien negativepressurewoundtherapyforthepreventionofsurgicalsiteinfectionsusingfasciaclosureafterevararandomizedtrial AT asciuttogiuseppe negativepressurewoundtherapyforthepreventionofsurgicalsiteinfectionsusingfasciaclosureafterevararandomizedtrial AT zarroukmoncef negativepressurewoundtherapyforthepreventionofsurgicalsiteinfectionsusingfasciaclosureafterevararandomizedtrial AT bjorkjonas negativepressurewoundtherapyforthepreventionofsurgicalsiteinfectionsusingfasciaclosureafterevararandomizedtrial AT biloslinda negativepressurewoundtherapyforthepreventionofsurgicalsiteinfectionsusingfasciaclosureafterevararandomizedtrial AT pirouzramartai negativepressurewoundtherapyforthepreventionofsurgicalsiteinfectionsusingfasciaclosureafterevararandomizedtrial AT acostastefan negativepressurewoundtherapyforthepreventionofsurgicalsiteinfectionsusingfasciaclosureafterevararandomizedtrial |